I am Professor of Neurology and Genomic Medicine at Imperial College London, and Honorary Consultant Neurologist at Imperial College Healthcare NHS Trust.
My research focuses on the systems-level integration of genetic, genomic and phenotypic data to identify causal functional pathways underlying disease. Using gene regulatory approaches, disease-associated functional pathways and cell-type specific gene expression signatures are then targeted to identify novel therapeutic strategies which cannot be captured using traditional reductionist strategies.
My research is funded by the MRC, UCB Pharma, the NIHR Biomedical Research Centres Scheme, the EU FP7 Framework and the Brain Tumour Research Campaign (www.wayahead-btrc.org).
My clinical activity is in general neurology and epilepsy with a particular focus on the autoimmune and tumour associated epilepsies. I am a core member of the Imperial College Healthcare neuro-oncology multidisciplinary team.
I am a member of the International League Against Epilepsy (ILAE) Task Force on Epigenetics, the Epi4K, EpiPGx and EPITARGET international consortia for epilepsy research, Epilepsy Action's Scientific Awards Panel, and an Advisor to the Commonwealth Scholarship Commission, the UK Parliamentary Health Ombudsman and Motorsport UK.
Fellow of the Royal College of Physicians (FRCP)
Fellow of the Royal Australasian College of Physicians (FRACP)
Fellow of the Royal Society of Medicine
Member of the Association of British Neurologists
Member of the British Medical Association
Member of International League Against Epilepsy